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Abstract
Background:  The thymus is the primary site for T-cell development and induction of self-
tolerance. Previous approaches towards manipulation of T-cell differentiation have used
intrathymic injection of antigens, as proteins, cells or adenoviruses, leading to transient expression
of the foreign protein. Lentiviral vectors, due to their unique ability to integrate into the genome
of quiescent cells, may be best suited for long-term expression of a transgene in the thymus.
Results: Young adult mice were injected in the thymus with lentiviral vectors expressing eGFP or
the hemaglutinin of the Influenza virus under the control of the ubiquitous phospho glycerate kinase
promoter. Thymi were examined 5 to 90 days thereafter directly under a UV-light microscope and
by flow cytometry. Intrathymic injection of lentiviral vectors predominantly results in infection of
stromal cells that could be detected for at least 3 months. Importantly, hemaglutinin expression by
thymic stromal cells mediated negative selection of thymocytes expressing the cognate T-cell
receptor. In addition and despite the low multiplicity of infection, transduced thymocytes were also
detected, even 30 days after injection.
Conclusions: Our results demonstrate that intrathymic delivery of a lentiviral vector is an efficient
means for stable expression of a foreign gene in the thymus. This new method of gene delivery may
prove useful for induction of tolerance to a specific antigen and for gene therapy of severe
combined immunodeficiencies.
Background
The thymus is a bilobate organ derived from embryonic
endoderm and mesoderm differentiation and is located
just above the heart (reviewed in [1]). It is the primary
organ for maturation of T cells. This process involves the
interaction between developing thymocytes and thymic
stromal cells. Thymic stromal cells which forms the
thymic architecture, have been classified according to
their anatomical localization. They encompass a very
diverse array of cell types, including cortical and medullar
epithelial cells, fibroblasts, macrophages and dendritic
cells (reviewed in [2]). Stromal cells control the differen-
tiation of haematopoietic precursors derived from the
liver or the bone marrow into T lymphocytes: T-cell differ-
entiation is defined by the acquisition of maturation
markers such as CD4, CD8 and the T-cell receptor com-
plex (TCR), which conditions the reactivity of immature
thymocytes with thymic stromal cells. The early thymo-
cyte progenitors entering the thymus do not express T-cell-
specific molecules, such as CD3, the alpha or beta-chain
of the TCR, or the CD4 and CD8 molecules. These CD4-
CD8- cells, referred to as double-negative (DN) cells, then
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become CD4+CD8+, the so-called double-positive (DP)
stage, and then progressively acquire TCR molecules. The
final maturation of T-cells involves the selective loss of
either the CD4 or the CD8 molecules to generate fully
mature single-positive (SP) cells with cytotoxic/suppres-
sor or helper/regulator function, respectively.
During this process, the TCR-mediated positive and nega-
tive selection of T cells ensures the selection of a diverse
TCR repertoire able to react with foreign peptide pre-
sented by autologous major histocompatibility complex
(MHC) molecules, but tolerant to self-antigens. This
property renders the thymus an attractive site for manipu-
lation of T-cell tolerance. To date, results on tolerance
induction via direct manipulation of the thymus have
been scarce (reviewed in [3]). However, previous studies
using intrathymic (IT) injection of pancreatic islet cells
[4], soluble antigens [5] or adenoviral vectors [6,7] have
shown that induction of tolerance to foreign antigens in
non-immunosuppressed animals is feasible. Since the
production and maturation of thymocytes may be a life-
long process, a major drawback to the utilisation of solu-
ble antigens or adenoviruses is their short-term expression
in the thymus [8]. Indeed, modulation of the selection
process should stop upon the disappearance of the anti-
gen, which might be a problem for long-term tolerance
induction.
Due to their ability to infect resting cells and to stably inte-
grate into the genome, lentiviral vectors represent power-
ful new tools for long-term expression of a given
transgene in vivo [9]. Lentiviral vectors have been used suc-
cessfully  in vivo to infect hepatocytes and muscle cells
[10], antigen-presenting cells [11,12], as well as cells of
the central nervous system [13]. We reasoned that lentivi-
ral vectors might be better suited than adenoviral vectors
for long-term IT expression of a foreign gene. We therefore
investigated the pattern of infection of a ubiquitous lenti-
viral vector after IT injection. We report herein that thymic
stromal cells are massively and persistently infected.
Developing thymocytes exhibit a significant but low level
of infection. Moreover, we show that IT injection of a len-
tiviral vector encoding the cognate antigen in TCR-trans-
genic (Tg) mice leads to negative selection of developing
thymocytes.
Results
Intrathymic injection of lentiviral vectors results in the 
efficient and persistent infection of thymic stromal cells
We used a concentrated viral stock of the LvPGK-GFP vec-
tor (2.109 TU143B/ml) to inject between 7 × 107 to 1.2 ×
108 infectious units in the thymus of normal C57Bl/6
mice. Infected cells could readily be detected at day 5 post-
injection by direct examination of the thymi under a UV
microscope (figure 1). Of note, transduced cells could still
be observed at 1 (figure 1) and 3 months (data not
shown) post injection. Most of the transduced cells had a
fibroblastic morphology. To monitor a possible passage
of the vector through the bloodstream, we checked for the
presence of transduced cells in the liver, which is the pri-
mary target organ after intravenous injection of lentiviral
vectors [14]. We indeed observed numerous eGFP+ cells in
the liver (figure 1), suggesting a significant leak into the
circulation upon IT injection of up to 30 µl of the vector.
Nevertheless, our results demonstrate efficient and per-
sistent infection of thymic stromal cells upon IT injection
of a lentiviral vector.
Induction of negative selection after intrathymic injection 
of lentiviral vectors
We next wanted to investigate whether thymic stromal
cells infected with a lentiviral vector would be able to
mediate negative selection of developing thymocytes. We
thus injected a lentiviral vector encoding the HA of the
Influenza virus, or eGFP as a control, into the thymus of
SFE-Tg mice expressing a TCR specific for a HA protein
peptide and for which a clonotypic antibody recognizing
the transgenic TCR (clone 6.5) is available [15]. Six days
after injection, we analyzed the thymocytes by flow
cytometry after thymi dilacerations. The frequency of 6.5+
cells within CD4SP and CD8SP thymocytes is shown in
figure 2A for a representative experiment. Intrathymic
injection of the LvPGK-HA vector resulted in a diminution
in the frequencies of 6.5+ cells within CD4SP by a factor of
2 and by a factor of 5 in CD8SP cells with an almost com-
plete disappearance of 6.5hi cells in the latter subset. Of
note is that the intensity of TCR transgenic expression was
reduced in CD4SP cells (figure 2A). Overall, we observed
a 3.5-fold decrease in the total numbers of thymocytes
expressing the specific TCR in mice injected with the
LvPGK-HA vector compared to the LvPGK-GFP vector (fig-
ure 2B). Our results altogether demonstrate that within a
week after intra thymic injection of the LvPGK-HA vector,
infected thymic stromal cells efficiently mediated negative
selection of HA-specific thymocytes.
Intrathymic injection of lentiviral vectors results in low 
level infection of immature thymocytes
We next investigated whether developing T-cells would be
infected upon IT injection of the lentiviral vector. Five
days post-injection of the LvPGK-GFP vector into the thy-
mus of a normal mouse, very few eGFP+ cells could be
detected by flow cytometry within the thymocytes
obtained from dilacerated thymi (figure 3). Most of these
cells were CD3- cells, and belonged to the DN and DP sub-
sets, showing that infected cells were mostly immature.
Interestingly, at day 30 post-injection, we observed more
mature eGFP+ cells that expressed CD3 and that belonged
to the subsets of CD4SP and CD8SP for more than half of
them. This result indicates that infection per se did notBMC Immunology 2004, 5:18 http://www.biomedcentral.com/1471-2172/5/18
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interfere with the normal process of T-cell development.
Moreover, we observed a similar repartition of CD4/CD8-
expressing cells in non-infected eGFP-  cells (data not
shown). Collectively, these results show that immature
thymocytes can be infected by in situ lentiviral infection.
However, we were unable to clearly detect infected T-cells
in the spleen of injected mice, likely due to their small rep-
resentation within the pool of mature lymphocytes in the
absence of a selective advantage for the transduced
thymocytes.
Discussion
We report herein that IT injection of a lentiviral vector
results in the predominant infection of thymic stromal
cells, and to a low level infection of thymocyte progeni-
tors. Significant infection of liver cells was also detected.
This observation is reminiscent of what was observed by
DeMatteo et al. with adenoviral vectors [7]. Together with
the fact that liver cells are main targets of IV-injected len-
tiviral or adenoviral vectors, this suggest that a significant
leak into the circulation does occur upon IT injection of
viral vectors. Our in situ analysis suggests that thymic epi-
thelial cells represent the vast majority of infected cells,
and studies are underway to more precisely define the
cells targeted by IT lentiviral injection. Whatever the pro-
portion of cortical, medullar epithelial cells, or thymic
dendritic cells that are transduced, we show here that this
results in an antigen presentation that efficiently mediates
negative selection of specific thymocytes. This is not due
to the injection of a "crude" preparation of viral superna-
tant that could have non-specifically affected T cell differ-
entiation. Indeed, we injected 10 times lower amounts of
p24 from the LvPGK-HA vector than of the LvPGK-GFP
vectors, suggesting that negative selection of HA-specific
thymocytes was a direct effect of HA expression by thymic
stromal cells. This is further supported by the analysis of
the frequencies of 6.5+ thymocytes which shows deletion
of 6.5hi  cells within CD8SP cells, an MHC class-II
In vivo expression of eGFP after intrathymic injection of the LvPGK-GFP vector Figure 1
In vivo expression of eGFP after intrathymic injection of the LvPGK-GFP vector. D5: day 5 post-injection localisa-
tion of transduced cells around the injection site (arrow) under visible and UV-lights (upper picture). Fibroblast-shaped cells 
are predominantly transduced (UV-light only) (lower panel). D30: day 30 post-injection expression of eGFP in the thymus (vis-
ible + UV-light) (upper panel) and in the liver (UV-light only) (lower panel). CTRL: Thymus (upper panel) and liver (lower 
panel) pictures from control mice injected IT with PBS examined for background fluorescence under visible and UV-lights. 
Magnifications are indicated in the lower right corner of each picture.BMC Immunology 2004, 5:18 http://www.biomedcentral.com/1471-2172/5/18
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restricted population in these TCR-transgenic mice [15].
Down modulation of the transgenic TCR and deletion was
observed within CD4SP cells. This is reminiscent of the
results obtained recently by Trani et al. which showed that
intra thymic delivery of increasing dose of the HA peptide
in SFE TCR-Tg mice resulted in the down regulation of the
transgenic TCR [16]. Therefore, deletion and/or receptor
down regulation may act in concert in the negative selec-
tion of HA-specific CD4SP cells in SFE transgenic mice.
A very low infection of developing thymocytes was
detected. This is not surprising as (i) the multiplicity of
infection (ratio of number of infectious units over
number of total cells in the thymus) was estimated to be
lower than 0.4 and (ii) lentiviral transduction of murine T
cells is far less efficient than of human T cells [17]. Since
the actual volume that can be injected in a mouse thymus
is however limited, we used the highest MOI achievable
with our concentrated vectors. It would be interesting to
assess if the use of vectors with higher infectious titres or
of repeated injections would lead to a better transduction
of thymocytes. It should be stressed though that at day 5
after injection, the infected cells represented immature
thymocytes not expressing CD3 molecules. At later time
points, infection was detected in more mature thymo-
cytes. We believe that this result may have important
implications for in vivo gene therapy of severe combined
immunodeficiencies (SCID) affecting T-cell development
(reviewed in [18]). Indeed, most of these diseases are due
to monogenic mutations and concerns immature
thymocytes, such as in the T-B+NK- deficiencies linked to
the common cytokine receptor gamma-c [19], or to the
ZAP-70 protein tyrosine kinase [20]. Our results open the
possibility of correcting these developmental blocks
through IT delivery of a lentiviral vector expressing a func-
tional molecule. For this particular application, it would
be important to avoid transgene expression in the thymic
stroma. The use of our recently described T-cell specific
Negative selection of developing thymocytes Figure 2
Negative selection of developing thymocytes (A) TCR transgenic expression within thymic CD8SP (white) and CD4SP 
cells (grey) identified by the anti-clonotypic monoclonal antibody 6.5 in SFE-Tg mice six days after IT injection of 40 to 60 ng 
p24 of the LvPGK-GFP lentiviral vector (n = 2) or of 3.5 to 6 ng p24 of the LvPGK-HA vector (n = 3). Shown are representa-
tive profile of two independent experiments. Numbers indicate the frequency of 6.5+ cells (B) Absolute counts of HA-specific 
thymocytes six days after intra thymic injection of LvPGK-GFP or LvPGK-HA lentiviral vectors. These figures were obtained 
based on the percentages of total 6.5+ thymocytes determined by flow cytometry as shown in (A). Statistical analysis was per-
formed using Student's t-test.BMC Immunology 2004, 5:18 http://www.biomedcentral.com/1471-2172/5/18
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lentiviral vector represent an attractive possibility towards
this end [21]. Given the tremendous proliferative
potential of T cells and the selective advantage that will be
provided by the transgene, even a low number of trans-
duced cells should result in a significant T cell reconstitu-
tion. This is best exemplified by a unique case of X-linked
severe combined immunodeficiency in which a reverse
mutation occurred in a single early T cell precursor. It was
determined that at least 1,000 T cell clones with unique T
cell receptor-beta sequences were generated from this pre-
cursor and that this diversity seems to be stable over time
and provides protection from infections in vivo [22]. Fur-
thermore, our preliminary results show that intra thymic
delivery of the ZAP-70 gene by mean of a T-cell specific
lentiviral vector in ZAP-70-deficient mice results in the
restoration of T-cell development (submitted). The pres-
ently described in vivo approach may represent an alterna-
tive to gene therapy protocols using cumbersome
haematopoietic stem cell manipulation ex vivo prior to
their reinfusion in vivo.
eGFP expression in developing thymocytes Figure 3
eGFP expression in developing thymocytes. Total thymocytes were stained with anti-CD4, anti-CD8 and anti-CD3 
monoclonal antibodies. Upper panels: saline-injected control mice (CTRL) and LvPGK-GFP-injected mice at two different time 
points after injection (D5 and D30) are shown. Lower panels: The profile of CD4/CD8 expression is shown within gated 
eGFP+ cells.BMC Immunology 2004, 5:18 http://www.biomedcentral.com/1471-2172/5/18
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Conclusions
Results presented herein may have important implica-
tions for the experimental and therapeutic manipulation
of the immune system, and notably for tolerance induc-
tion and the correction of SCID.
Methods
Mice and intrathymic surgery
C57Bl/6 mice were obtained from Charles River/IFFA
Credo Laboratories (Les Oncins, France) at 6 weeks of age
and were used at 8 to 10 weeks-old. SFE TCR-Tg mice [15]
were bred in our own animal facility and were used at 6 to
10 weeks-old. Intrathymic surgery was performed after
anesthetic treatment of animals with 40 mg/kg of Pento-
barbital (Sanofi-Synthelabo, Gentilly, France). Mid-inci-
sion of the lower neck was performed to gain access to the
trachea. Incision of the sternum was performed on the
first two ribs and gently pulled aside to view the thymus.
A single injection of 10 to 30 µl was performed using 0.3
ml Terumo insulin syringes (VWR, Fontenay-sous-bois,
France).
Lentiviral vector construction, production, concentration 
and quantification
The plasmid encoding the lentiviral vector
pRRLsin.PPT.hPGK.GFPpre (LvPGK-GFP) has been
described elsewhere [23] (kindly provided by L. Naldini
(University of Torino Medical School, Torino, Italy). To
construct the plasmid encoding the hemaglutinin (HA)
protein of the Influenza virus, BamHI and SalI restriction
sites at the 5' and 3' ends, respectively, were added to the
cDNA of the HA protein of Influenza virus (H1N1) in the
pCIneoHA plasmid (provided by Genethon, Evry, France)
by PCR using the Taq polymerase (Invitrogen, Cergy-Pon-
toise, France). Total PCR products were cloned into the TA
vector (Invitrogen), checked for sequence integrity and
digested with BamHI/SalI. The plasmid
pRRLsin.PPT.hPGK.GFPpre was digested with BamHI/
SalI (New England Biolabs, Beverly, Massachussets, USA)
to remove eGFP. After ligation, the plasmid
pRRLsin.PPT.hPGK.HApre, hereafter referred to as
LvPGK-HA, was obtained. To produce lentiviral vectors, a
total of 4.106  293T-cells were co-transfected with the
transfer vector, the packaging and the envelope plasmids
in 10-cm dishes using the calcium phosphate method as
described [21] in DMEM supplemented with serum and
antibiotics (Lifetechnologies, Gaithersburg, Maryland,
USA). Lentiviral supernatants were collected at 18, 42 and
66 hrs post co-transfection in serum-free DMEM supple-
mented with antibiotics and L-glutamine, and concen-
trated by ultrafiltration using either the Ultrafree-15 or the
Centricon Plus-80 filter devices according to the manufac-
turer instructions (Millipore, Bedford, Massachussets,
USA). Briefly, supernatants were applied to the filter
devices and spun at 2000 g for 20 min. at 20°C. Concen-
trated supernatants were aliquoted and kept at -80°C
until use. Viral stocks of the LvPGK-GFP lentiviral vector
were titered on 143B cells as previously described [21].
Viral stocks of the LvPGK-GFP and LvPGK-HA vectors
were also quantified using a gag p24 ELISA (Zeptometrix,
Buffalo, New York, USA).
Microscopy and images treatment
Whole thymus or liver were excised from injected mice
and placed in PBS 1X in a 6-well plate. Pictures of the
whole organ were acquired using a DP-11 numeric camera
coupled with the CK-40 inverted microscope equipped
with a mercury lamp (Olympus France S.A, Rungis,
France). Images were processed using Adobe Photoshop
(Adobe Systems Inc., San Jose, California, USA).
Flow cytometry
Thymi were dilacerated between two frosted slides in 1X
PBS supplemented with 3% Fetal Calf Serum (Lifetech-
nologies). Cell suspensions were numerated and 106 cells
were stained with the following monoclonal antibodies
(Becton Dickinson Biosciences, le Pont de Claix, France):
CD4-APC (allophycocyanin), CD8-CyCr (Cychrome) and
either CD3 or pan beta-chain of the TCR-PE (phycoery-
trin) or purified anti-clonotypic TCR for the HA peptide
SFERFEIFPK presented by MHC class II I-Ed (clone 6.5)
([15]) followed by biotinylated anti-rat IgG2b and
streptavidin-FITC. Data were collected on a FACScalibur
(BD Biosciences) and analysed with FlowJo software (Tre-
eStar, Ashland, Oregon, USA).
Abbreviations
DN: double negative
DP: double positive
SP: single positive
IT: intra thymic
IV: intra venous
HA: hemaglutinin
MOI: multiplicity of infection
SCID: severe combined immunodeficiencies
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